about
P185
Global profiling of co- and post-translationally N-myristoylated proteomes in human cellsN-myristoyltransferase inhibitors as new leads to treat sleeping sicknessThe crystal structures of macrophage migration inhibitory factor from Plasmodium falciparum and Plasmodium bergheiDomain swapping in the sporulation response regulator Spo0AStructure of the Bacillus cell fate determinant SpoIIAA in phosphorylated and unphosphorylated formsThe crystal structure of gankyrin, an oncoprotein found in complexes with cyclin-dependent kinase 4, a 19 S proteasomal ATPase regulator, and the tumor suppressors Rb and p53A bacterial virulence factor with a dual role as an adhesin and a solute-binding protein: the crystal structure at 1.5 A resolution of the PEB1a protein from the food-borne human pathogen Campylobacter jejuniStructure and non-essential function of glycerol kinase inPlasmodium falciparumblood stagesThe structure of Rph, an exoribonuclease fromBacillus anthracis, at 1.7 Å resolutionThe crystal structures of human S100A12 in apo form and in complex with zinc: new insights into S100A12 oligomerisationN-Myristoyltransferase from Leishmania donovani: Structural and Functional Characterisation of a Potential Drug Target for Visceral LeishmaniasisStructure of the catalytic domain of the human mitochondrial Lon protease: Proposed relation of oligomer formation and activityStructural basis for the efficient phosphorylation of AZT-MP (3'-azido-3'-deoxythymidine monophosphate) and dGMP by Plasmodium falciparum type I thymidylate kinaseThe Structure and Interactions of SpoIISA and SpoIISB, a Toxin-Antitoxin System in Bacillus subtilisCompensating Stereochemical Changes Allow Murein Tripeptide to Be Accommodated in a Conventional Peptide-binding ProteinStructure and Organisation of SinR, the Master Regulator of Biofilm Formation in Bacillus subtilisDesign and Synthesis of Inhibitors of Plasmodium falciparumN -Myristoyltransferase, A Promising Target for Antimalarial Drug DiscoveryDiscovery of Novel and Ligand-Efficient Inhibitors of Plasmodium falciparum and Plasmodium vivax N -MyristoyltransferaseStructure of the Phosphatase Domain of the Cell Fate Determinant SpoIIE from Bacillus subtilisCrystal and Solution Studies Reveal That the Transcriptional Regulator AcnR of Corynebacterium glutamicum Is Regulated by Citrate-Mg2+ Binding to a Non-canonical PocketStructure of components of an intercellular channel complex in sporulating Bacillus subtilisDiscovery of Plasmodium vivax N -Myristoyltransferase Inhibitors: Screening, Synthesis, and Structural Characterization of their Binding ModeValidation of N-myristoyltransferase as an antimalarial drug target using an integrated chemical biology approachMpaA is a murein-tripeptide-specific zinc carboxypeptidase that functions as part of a catabolic pathway for peptidoglycan-derived peptides in γ-proteobacteriaDesign and Synthesis of High Affinity Inhibitors of Plasmodium falciparum and Plasmodium vivax N -Myristoyltransferases Directed by Ligand Efficiency Dependent Lipophilicity (LELP)Structure and interactions of theBacillus subtilissporulation inhibitor of DNA replication, SirA, with domain I of DnaADiverse modes of binding in structures ofLeishmania majorN-myristoyltransferase with selective inhibitorsStructure of the virulence-associated protein VapD from the intracellular pathogenRhodococcus equiThe role of water in sequence-independent ligand binding by an oligopeptide transporter proteinStabilizing bound O2 in myoglobin by valine68 (E11) to asparagine substitutionSelective inhibitors of protozoan protein N-myristoyltransferases as starting points for tropical disease medicinal chemistry programsStructural and biochemical characterization of a mitochondrial peroxiredoxin from Plasmodium falciparumStructural characterisation of the virulence-associated protein VapG from the horse pathogen Rhodococcus equi.The crystal structure of YloQ, a circularly permuted GTPase essential for Bacillus subtilis viability.Structure of the Branched-chain Amino Acid and GTP-sensing Global Regulator, CodY, from Bacillus subtilis.Raman and CD spectroscopy of recombinant 68-kDa DNA human topoisomerase I and its complex with suicide DNA-substrate.Crystallization of full-length CysB of Klebsiella aerogenes, a LysR-type transcriptional regulator.The crystal structure of superoxide dismutase from Plasmodium falciparum.Expression of soluble, active fragments of the morphogenetic protein SpoIIE from Bacillus subtilis using a library-based construct screen.A widespread family of serine/threonine protein phosphatases shares a common regulatory switch with proteasomal proteases.
P50
Q24304441-6BF5EA35-0A99-4A4D-8DE8-A0517C37B36DQ24594745-BD32C7DA-92AE-4023-8B65-321959CBC278Q24654129-5D9E3CC0-3A67-41AC-8877-ED99D9AAC618Q27621840-F9E56CFD-9B7A-4340-8FD5-46AA7D22D80CQ27633593-C3BCE1C2-237C-4B76-98AD-F858D077DA56Q27642398-46414043-06D1-41EE-83FE-881102B2FCE1Q27646715-58DCB6D7-1892-4CBF-8135-BA3A00692FC1Q27653012-D81B74F2-C249-4E10-864B-B9B6F8CFA1D4Q27653456-6E1F33DE-A957-4DC2-9336-975E3260FB11Q27655773-F1FEDC2D-0255-4DF0-A24F-F30661836173Q27658775-262D4C8B-DE3A-48D3-B228-A8059C400D15Q27660181-18BD1313-AC12-4FBB-8BCE-C27B2FD0D4ECQ27660369-87315B25-01CD-498A-B302-E3DEB3D40458Q27666312-CE2268F9-4814-428C-9101-B6FDEADB3799Q27670557-11004E9E-C0B0-45B0-B3BE-CCC0B8E2B8DCQ27670586-8E1348CE-3E26-485E-BA8D-EEC22C4E9291Q27674217-FB48667C-DBE5-4DE2-9BC2-379F1BC2472EQ27675197-70491688-5CE8-4AEF-9984-C63DE1CF94A4Q27675791-582AF032-8FE0-4A06-9A97-8AB01541D33CQ27677392-21348615-7FFC-4301-B631-FFAFF4F09664Q27678101-DE63405D-0AD6-4B93-8F3B-6E13D4298815Q27678157-D0251894-E4A8-473D-BD66-0D7D15BAE09DQ27681425-E7871BB0-2E77-4B8D-B875-684D00B63754Q27682238-28005FE8-3B1D-4D48-994B-6FF8B18A3DBDQ27682285-1E42A13D-C05D-4DFA-A00E-265BC4A4575BQ27684736-54BBB154-BEDC-4C72-98B9-8A4323632F3CQ27684875-F68B8E20-85D4-4016-88B0-044D3D72EFB0Q27684901-0BA84F1C-2A19-430D-96E1-0F259812CE6FQ27734061-F848C76A-BC42-4FA1-8FFE-A964D33C8628Q27766135-BB67C0D5-8E91-4CAA-BC2D-38E4F77C294AQ28482502-6DEB0994-4F50-4551-B57C-75991EF0E9A9Q30042256-4BC443CB-254A-431B-B80C-4B212D905127Q30152972-4AF98DA5-B3E2-46CB-9CA4-85561A205FFBQ30163979-C1A45284-B20C-4596-91D0-21BBC072F096Q30396776-2B90B57A-1806-48AF-9BC0-0957928E081CQ30431663-AA393635-03BF-43E7-AC73-C95435836AF6Q31927059-27246E23-9E2D-46A8-91ED-F3EEA88495F7Q33259345-2D2A1C4A-85AD-4C08-940C-6AC6C8CD9EB6Q33684517-10732B8D-6E92-435F-8542-D9C2BAC83337Q33788930-2E62A5D8-4B97-4A78-8E4A-97085B9E3BB4
P50
description
British biochemist
@en
Brits biochemicus
@nl
bioquímicu británicu
@ast
name
Tony Wilkinson
@ast
Tony Wilkinson
@br
Tony Wilkinson
@ca
Tony Wilkinson
@co
Tony Wilkinson
@cs
Tony Wilkinson
@da
Tony Wilkinson
@de
Tony Wilkinson
@en
Tony Wilkinson
@es
Tony Wilkinson
@fr
type
label
Tony Wilkinson
@ast
Tony Wilkinson
@br
Tony Wilkinson
@ca
Tony Wilkinson
@co
Tony Wilkinson
@cs
Tony Wilkinson
@da
Tony Wilkinson
@de
Tony Wilkinson
@en
Tony Wilkinson
@es
Tony Wilkinson
@fr
altLabel
Anthony J Wilkinson
@en
Anthony J. Wilkinson
@en
Anthony Wilkinson
@en
prefLabel
Tony Wilkinson
@ast
Tony Wilkinson
@br
Tony Wilkinson
@ca
Tony Wilkinson
@co
Tony Wilkinson
@cs
Tony Wilkinson
@da
Tony Wilkinson
@de
Tony Wilkinson
@en
Tony Wilkinson
@es
Tony Wilkinson
@fr
P106
P1153
7201829014
P184
P21
P31
P496
0000-0003-4577-9479